BRPI1011034A2 - vacina de gripe universal baseada no vírus ancara vaccinia modificado (mva) recombinante - Google Patents
vacina de gripe universal baseada no vírus ancara vaccinia modificado (mva) recombinanteInfo
- Publication number
- BRPI1011034A2 BRPI1011034A2 BRPI1011034A BRPI1011034A BRPI1011034A2 BR PI1011034 A2 BRPI1011034 A2 BR PI1011034A2 BR PI1011034 A BRPI1011034 A BR PI1011034A BR PI1011034 A BRPI1011034 A BR PI1011034A BR PI1011034 A2 BRPI1011034 A2 BR PI1011034A2
- Authority
- BR
- Brazil
- Prior art keywords
- mva
- influenza vaccine
- modified vaccinia
- vaccinia ankara
- recombinant modified
- Prior art date
Links
- 241001183012 Modified Vaccinia Ankara virus Species 0.000 title 1
- 229960003971 influenza vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24141—Use of virus, viral particle or viral elements as a vector
- C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1015DE2009 | 2009-05-18 | ||
| PCT/IN2010/000314 WO2010134094A1 (en) | 2009-05-18 | 2010-05-17 | Universal influenza vaccine based on recombinant modified vaccinia ankara virus (mva) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI1011034A2 true BRPI1011034A2 (pt) | 2016-03-15 |
Family
ID=43125819
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1011034A BRPI1011034A2 (pt) | 2009-05-18 | 2010-05-17 | vacina de gripe universal baseada no vírus ancara vaccinia modificado (mva) recombinante |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20120141525A1 (pt) |
| EP (2) | EP2550974A3 (pt) |
| JP (1) | JP2012527232A (pt) |
| KR (1) | KR20120096874A (pt) |
| CN (1) | CN102740880A (pt) |
| AR (1) | AR076690A1 (pt) |
| AU (1) | AU2010250780A1 (pt) |
| BR (1) | BRPI1011034A2 (pt) |
| CA (1) | CA2762044A1 (pt) |
| CL (1) | CL2011002913A1 (pt) |
| EA (1) | EA201171436A1 (pt) |
| MX (1) | MX2011012312A (pt) |
| WO (1) | WO2010134094A1 (pt) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011087839A1 (en) * | 2009-12-22 | 2011-07-21 | Baxter International Inc. | Vaccine to influenza a virus |
| WO2012048817A2 (en) * | 2010-10-15 | 2012-04-19 | Bavarian Nordic A/S | Recombinant modified vaccinia virus ankara influenza vaccine |
| CN102140441B (zh) * | 2010-11-04 | 2013-12-18 | 高福 | 基于减毒痘苗病毒天坛株为载体的禽流感疫苗 |
| WO2012085936A2 (en) | 2010-12-20 | 2012-06-28 | Panacea Biotech Ltd | Recombinant respiratory syncytial virus plasmids and vaccines |
| WO2012106231A2 (en) | 2011-01-31 | 2012-08-09 | Baxter International Inc. | Recombinant viral vectors and methods for inducing a heterosubtypic immune response to influenza a viruses |
| CN102653771B (zh) * | 2011-10-29 | 2014-10-29 | 上海师范大学 | 谷氨酰胺转运蛋白1融合蛋白表达载体的应用 |
| US9463238B2 (en) * | 2011-12-09 | 2016-10-11 | Bavarian Nordic A/S | Recombinant poxvirus vector comprising tetanus toxin fragment C |
| WO2014005643A1 (en) * | 2012-07-05 | 2014-01-09 | Okairos Ag | Novel prime-boosting regimens involving immunogenic polypeptides encoded by polynucleotides |
| MX384992B (es) | 2014-06-13 | 2025-03-14 | Glaxosmithkline Biologicals Sa | Combinaciones inmunógenas. |
| WO2018013704A1 (en) | 2016-07-12 | 2018-01-18 | Duke University | Engineered influenza polynucleotides, viruses, vaccines and methods of making and using the same |
| WO2020163768A1 (en) * | 2019-02-07 | 2020-08-13 | Duke University | Stabilized 9 and 10 segmented influenza viruses as a vaccine platform and methods of making and using same |
| KR102334320B1 (ko) * | 2019-11-08 | 2021-12-03 | 서울대학교산학협력단 | Ｈ９ｎ２ 재조합 인플루엔자 바이러스, 이의 제조용 조성물, 및 이를 포함하는 백신 조성물 |
| KR102277089B1 (ko) * | 2019-12-19 | 2021-07-14 | 에스케이바이오사이언스(주) | A형 간염 바이러스의 제조방법 및 상기의 방법에 따라 제조된 a형 간염 바이러스 |
| CN111926043A (zh) * | 2020-08-10 | 2020-11-13 | 中国农业科学院兰州兽医研究所 | 共表达fmdv和pprv抗原基因重组病毒的构建方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8506967B2 (en) * | 2003-07-11 | 2013-08-13 | Novavax, Inc. | Functional influenza virus like particles (VLPs) |
| EA200701097A1 (ru) * | 2004-11-19 | 2007-10-26 | Висконсин Эламни Рисёч Фаундэйшн | Рекомбинантные векторы вируса гриппа с тандемными транскрипционными единицами |
| US7736642B2 (en) * | 2006-02-02 | 2010-06-15 | Globeimmune, Inc. | Yeast-based vaccine for inducing an immune response |
| EP1925318A1 (en) * | 2006-11-20 | 2008-05-28 | Paul-Ehrlich-Institut | Recombinant modified vaccinia virus Ankara (MVA)-based vaccine for the avian flu |
| GB0719526D0 (en) * | 2007-10-05 | 2007-11-14 | Isis Innovation | Compositions and methods |
-
2010
- 2010-05-17 AU AU2010250780A patent/AU2010250780A1/en not_active Abandoned
- 2010-05-17 KR KR1020117030091A patent/KR20120096874A/ko not_active Withdrawn
- 2010-05-17 CN CN2010800218637A patent/CN102740880A/zh active Pending
- 2010-05-17 EA EA201171436A patent/EA201171436A1/ru unknown
- 2010-05-17 EP EP11192023.7A patent/EP2550974A3/en not_active Withdrawn
- 2010-05-17 JP JP2012511410A patent/JP2012527232A/ja not_active Withdrawn
- 2010-05-17 WO PCT/IN2010/000314 patent/WO2010134094A1/en not_active Ceased
- 2010-05-17 BR BRPI1011034A patent/BRPI1011034A2/pt not_active Application Discontinuation
- 2010-05-17 EP EP10777464A patent/EP2432503A4/en not_active Withdrawn
- 2010-05-17 CA CA2762044A patent/CA2762044A1/en not_active Abandoned
- 2010-05-17 MX MX2011012312A patent/MX2011012312A/es not_active Application Discontinuation
- 2010-05-17 US US13/321,133 patent/US20120141525A1/en not_active Abandoned
- 2010-05-18 AR ARP100101729A patent/AR076690A1/es unknown
-
2011
- 2011-11-18 CL CL2011002913A patent/CL2011002913A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2762044A1 (en) | 2010-11-25 |
| EP2432503A4 (en) | 2013-01-23 |
| MX2011012312A (es) | 2011-12-16 |
| WO2010134094A9 (en) | 2011-02-03 |
| AU2010250780A1 (en) | 2012-01-12 |
| JP2012527232A (ja) | 2012-11-08 |
| AR076690A1 (es) | 2011-06-29 |
| EP2550974A2 (en) | 2013-01-30 |
| US20120141525A1 (en) | 2012-06-07 |
| WO2010134094A1 (en) | 2010-11-25 |
| EA201171436A1 (ru) | 2012-04-30 |
| EP2550974A3 (en) | 2013-05-08 |
| EP2432503A1 (en) | 2012-03-28 |
| CL2011002913A1 (es) | 2012-04-20 |
| KR20120096874A (ko) | 2012-08-31 |
| CN102740880A (zh) | 2012-10-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI1011034A2 (pt) | vacina de gripe universal baseada no vírus ancara vaccinia modificado (mva) recombinante | |
| IL236744B (en) | A modified recombinant vaccinia ankara virus respiratory syncytial virus assembly | |
| IL261204A (en) | Influenza virus vaccines and their use | |
| SG11201701506PA (en) | Recombinant modified vaccinia virus ankara (mva) filovirus vaccine | |
| BR112012030950A2 (pt) | formulações de vacina | |
| BRPI0911604A2 (pt) | vacinas de polipeptídeo de flagelina | |
| DK2488649T3 (da) | Rekombinant modificeret vaccinia ankara (mva)-vaccinia-virus indeholdende restrukturerede insertionssteder | |
| EP2632485A4 (en) | DENGUE VIRUS VACCINE WITH A RECOMBINANT SUB-UNIT | |
| EP2552479A4 (en) | INFLUENZA VIRUS VACCINES AND USES THEREOF | |
| EP2525818A4 (en) | IMMUNOGENEOUS INFLUENZA COMPOSITION | |
| BR112012005774A2 (pt) | terapia anticancerígena de combinação do vaccinia vírus oncolítico | |
| EP2914283A4 (en) | UNIVERSAL FLUID VACCINE BASED ON MULTIPLE HETEROLOGER M2E PROTEINS | |
| EP2529227A4 (en) | CYTOMEGOOVIRUS BASED IMMUNOGENIC PREPARATIONS | |
| ZA201500606B (en) | Recombinant modified vaccinia virus ankara (mva) respiratory syncytial virus (rsv) vaccine | |
| EP2646052A4 (en) | LYOPHILIZED VIRAL FORMULATIONS | |
| IL213189A0 (en) | Recombinant avian influenza vaccine and uses thereof | |
| IL224022B (en) | Thermally stable influenza vaccine | |
| EP2595653A4 (en) | INFLUENZA VACCINE | |
| SG11201500439RA (en) | Vaccine compositions for prevention against dengue virus infection | |
| EP2875813A4 (en) | PROPHYLACTIC OR THERAPEUTIC ACTIVE AGAINST FLUID VIRUS INFECTION | |
| SMT201400170B (it) | Vaccino contro hpv | |
| ZA200809056B (en) | Influenza virus vaccine | |
| EP2117589A4 (en) | FLAVIVIRUS VACCINE VECTOR AGAINST INFLUENZA VIRUS | |
| GB0918679D0 (en) | Influenza vaccine | |
| ZA201104013B (en) | Recombinant inactivated viral vector vaccine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |